BPA Call HT001414A0004-0005
Award Date 11/25/14
Potential Completion Date 12/3/14
Potential Value $150K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20889, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a Firm Fixed Price BPA Call contract awarded by the Defense Health Agency (DHA) to TDS Med, Inc., a self-certified small disadvantaged business. The $300,000 contract is for the supply of shortage pharmaceutical items, including pharmaceuticals, blood products, medical inhalations, and injectables, to support the Bureau of Medicine and Surgery's requirements. This award is a task order issued under a $2 million Blanket Purchase Agreement (BPA) awarded to TDS Med, Inc. by the DHA in...
- The U.S. Defense Health Agency awarded a Firm Fixed Price Blanket Purchase Agreement (BPA) Call contract to TDS Med, Inc., a small disadvantaged business, to provide pharmaceutical shortage supplies. The contract has a ceiling value of $150,000.00 and a period of performance ending on September 30, 2014. This contract is issued under a larger $2 million BPA awarded to TDS Med, Inc. in September 2019 to provide pharmaceutical products and supplies to the Defense Health Agency. TDS Med, Inc. has...
- This federal contract award to TDS Med, Inc., a self-certified small disadvantaged business, was issued by the Defense Health Agency. The $300,000.00 contract is a Blanket Purchase Agreement (BPA) call to provide a variety of pharmaceutical products, including blood products, oncological pharmaceuticals, injectables, orals, and medical inhalations to address shortages. The contract has a period of performance through March 31, 2018 and uses a firm fixed-price pricing type. This BPA is part of...
- The U.S. Defense Health Agency awarded a firm-fixed-price Blanket Purchase Agreement (BPA) call worth up to $300,000 to TDS Med, Inc., a self-certified small disadvantaged business, to provide pharmaceuticals, blood products, and other medical items including injectables, orals, and inhalations. This BPA was established in September 2019 and has a 5-year ordering period. TDS Med, Inc. has previously provided COVID-19 response and pharmaceutical shortage support to the Department of Defense and...
- This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the Department of Defense's Bureau of Medicine and Surgery to TDS Med, Inc., a self-certified small disadvantaged business, to provide various pharmaceutical products. The $250,000 award has an ultimate completion date of September 30, 2015. TDS Med, Inc. has provided pharmaceutical products and medical supplies in support of COVID-19 response efforts and to address shortages for the Defense Health Agency and...
- This is a federal contract award to TDS Med, Inc., a self-certified small disadvantaged business, for the provision of pharmaceutical products to address shortages. The contract was issued by the Defense Health Agency, a defense agency, with a period of performance ending on September 30, 2016 and a ceiling value of $396,538.98. The contract was awarded on a Firm Fixed Price basis under a Blanket Purchase Agreement (BPA) vehicle. No set-aside designation was used. TDS Med, Inc. has previously...
- This $150,000 firm-fixed-price contract was awarded to TDS Med, Inc., a self-certified small disadvantaged business, by the Bureau of Medicine and Surgery (BUMED), a component of the U.S. Department of Defense. The contract is for the provision of pharmaceutical shortage items, including blood products, injectables, and medical inhalations, to support BUMED's mission. This contract is a call against a larger $2 million Blanket Purchase Agreement (BPA) that TDS Med, Inc. holds with the Defense...
- This is a firm fixed-price BPA call awarded by the Defense Health Agency (DHA) to TDS Med, Inc., a self-certified small disadvantaged business, to provide shortage pharmaceuticals, blood products, oncological products, injectables, orals, and medical inhalations. The $264,000 contract has an ultimate completion date of September 30, 2019. TDS Med, Inc. is an active federal contractor, holding a $2 million Blanket Purchase Agreement with the DHA to provide pharmaceutical products and supplies...
- This is a firm fixed-price Blanket Purchase Agreement (BPA) award to TDS Med, Inc., a small disadvantaged business, by the Defense Health Agency (DHA) for pharmaceutical products. The contract has a ceiling value of $150,000.00 and a period of performance through September 30, 2015. This BPA is part of a larger $2 million IDV (Indefinite Delivery Vehicle) contract awarded to TDS Med, Inc. in September 2019 to provide shortage pharmaceuticals, blood products, medical inhalations, injectables, and...
- This is a firm fixed-price Blanket Purchase Agreement (BPA) call contract awarded by the Defense Health Agency (DHA) to TDS Med, Inc., a self-certified small disadvantaged business, to provide pharmaceutical supplies and drugs for the Walter Reed National Military Medical Center (WRNMMC). The $300,000 contract has an ultimate completion date of September 30, 2015 and was awarded on June 30, 2015. TDS Med, Inc. is an active federal contractor that has previously supported COVID-19 response...